Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Vitrolife AB

Market Cap 12.99B 1.38B 1.19B 1.1B 1.03B 1.94B 131B 1.96B 5.07B 64.09B 5.2B 5.09B 222B P/E Ratio 2026 *
26.4x
P/E Ratio 2027 * 21.3x
Enterprise Value 13.32B 1.42B 1.22B 1.13B 1.06B 1.98B 134B 2B 5.2B 65.72B 5.33B 5.22B 227B EV / Sales 2026 *
3.8x
EV / Sales 2027 * 3.38x
Free-Float
54.39%
Yield 2026 *
1.11%
Yield 2027 * 0.95%
1 day-2.61%
1 week-1.59%
Current month-5.86%
1 month-10.74%
3 months-1.17%
6 months-30.68%
Current year-32.04%
1 week 93.1
Extreme 93.1
98.2
1 month 93.1
Extreme 93.1
110.4
Current year 84.6
Extreme 84.6
139.6
1 year 84.6
Extreme 84.6
153.5
3 years 84.6
Extreme 84.6
268
5 years 84.6
Extreme 84.6
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 2023-07-31
Director of Finance/CFO 55 2025-10-09
Chief Investment Officer 39 -
Director TitleAgeSince
Director/Board Member 63 2013-04-18
Chairman 70 2023-07-31
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
Feb. 05Buy

Chief Executive Officer

3,013 0.0022%
Feb. 05Buy

Chief Operating Officer

6,470 0.0048%
Feb. 03Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
-2.61%-1.59%-34.80%-59.09% 1.38B
-1.37%+3.95%+163.38%+242.89% 17.21B
+0.67%-4.77%-43.79%-26.47% 9.23B
+0.14%+4.66%+34.49%+16.55% 6.81B
+1.17%+12.64% - - 5.14B
+0.18%-2.39%-27.83%-31.57% 5.07B
+10.00%-1.44%+85.21%+82.98% 4.14B
-0.80%-5.63%-28.98%-33.76% 4.14B
+11.72%+10.42%+209.36%-45.13% 4.09B
+2.66%+6.26%-14.34%-40.87% 2.71B
Average +2.23%+2.65%+38.08%+11.73% 5.99B
Weighted average by Cap. +1.39%+2.42%+63.96%+67.83%

Financials

2026 *2027 *
Net sales 3.5B 374M 322M 296M 278M 522M 35.32B 528M 1.37B 17.3B 1.4B 1.37B 59.85B 3.77B 402M 347M 319M 300M 563M 38.04B 568M 1.47B 18.63B 1.51B 1.48B 64.46B
Net income 491M 52.39M 45.15M 41.55M 38.98M 73.23M 4.95B 73.96M 192M 2.42B 197M 192M 8.39B 610M 65.02M 56.04M 51.57M 48.38M 90.88M 6.14B 91.79M 238M 3.01B 244M 239M 10.41B
Net Debt 330M 35.15M 30.29M 27.88M 26.16M 49.13M 3.32B 49.62M 129M 1.63B 132M 129M 5.63B -222M -23.65M -20.38M -18.76M -17.6M -33.06M -2.24B -33.39M -86.63M -1.09B -88.75M -86.87M -3.79B
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,126
Date Price Change Volume
26-06-16 92.10 kr -3.96% 86,888
26-06-15 95.90 kr +0.16% 185,116
26-06-12 95.75 kr -0.47% 745,674
26-06-11 96.20 kr +0.31% 262,362
26-06-10 95.90 kr +1.37% 644,662
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
95.90SEK
Average target price
162.75SEK
Spread / Average Target
+69.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!